Royce W. Waltrip

2.1k total citations · 1 hit paper
33 papers, 1.5k citations indexed

About

Royce W. Waltrip is a scholar working on Epidemiology, Nephrology and Psychiatry and Mental health. According to data from OpenAlex, Royce W. Waltrip has authored 33 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 8 papers in Nephrology and 8 papers in Psychiatry and Mental health. Recurrent topics in Royce W. Waltrip's work include Virology and Viral Diseases (10 papers), Gout, Hyperuricemia, Uric Acid (8 papers) and Viral Infections and Immunology Research (6 papers). Royce W. Waltrip is often cited by papers focused on Virology and Viral Diseases (10 papers), Gout, Hyperuricemia, Uric Acid (8 papers) and Viral Infections and Immunology Research (6 papers). Royce W. Waltrip collaborates with scholars based in United States, New Zealand and Japan. Royce W. Waltrip's co-authors include Kathryn M. Carbone, Allan N. Maroli, Steven A. Rubin, Michael A. Becker, Herbert S. B. Baraf, William J. Huang, Robert W. Buchanan, John S. Sundy, Alan Breier and William T. Carpenter and has published in prestigious journals such as JAMA, The Journal of Immunology and American Journal of Psychiatry.

In The Last Decade

Royce W. Waltrip

31 papers receiving 1.5k citations

Hit Papers

Efficacy and Tolerability of Pegloticase for the Treatmen... 2011 2026 2016 2021 2011 100 200 300

Peers

Royce W. Waltrip
J Dormont France
Kay Poulton United Kingdom
Michael D. Schuffler United States
T. L. Vischer Switzerland
J. Huber Netherlands
J Dormont France
Royce W. Waltrip
Citations per year, relative to Royce W. Waltrip Royce W. Waltrip (= 1×) peers J Dormont

Countries citing papers authored by Royce W. Waltrip

Since Specialization
Citations

This map shows the geographic impact of Royce W. Waltrip's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Royce W. Waltrip with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Royce W. Waltrip more than expected).

Fields of papers citing papers by Royce W. Waltrip

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Royce W. Waltrip. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Royce W. Waltrip. The network helps show where Royce W. Waltrip may publish in the future.

Co-authorship network of co-authors of Royce W. Waltrip

This figure shows the co-authorship network connecting the top 25 collaborators of Royce W. Waltrip. A scholar is included among the top collaborators of Royce W. Waltrip based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Royce W. Waltrip. Royce W. Waltrip is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gold, Laura S., et al.. (2020). <p>Medication Utilization Patterns 90 Days Before Initiation of Treatment with Repository Corticotropin Injection in Patients with Infantile Spasms</p>. Pediatric Health Medicine and Therapeutics. Volume 10. 195–207. 1 indexed citations
2.
Waltrip, Royce W., et al.. (2018). Relapse prevalence, symptoms, and health care engagement: patient insights from the Multiple Sclerosis in America 2017 survey. Multiple Sclerosis and Related Disorders. 26. 219–234. 40 indexed citations
3.
Becker, Michael A., H. Ralph Schumacher, Katy Benjamin, et al.. (2009). Quality of Life and Disability in Patients with Treatment-Failure Gout. The Journal of Rheumatology. 36(5). 1041–1048. 135 indexed citations
4.
Grainger, Rebecca, William J. Taylor, Nicola Dalbeth, et al.. (2009). Progress in Measurement Instruments for Acute and Chronic Gout Studies. The Journal of Rheumatology. 36(10). 2346–2355. 38 indexed citations
5.
Taylor, W, Richard M. Shewchuk, Kenneth G. Saag, et al.. (2009). Toward a valid definition of gout flare: Results of consensus exercises using delphi methodology and cognitive mapping. Arthritis Care & Research. 61(4). 535–543. 26 indexed citations
6.
Baraf, Herbert S. B., Alan K. Matsumoto, Allan N. Maroli, & Royce W. Waltrip. (2008). Resolution of gouty tophi after twelve weeks of pegloticase treatment. Arthritis & Rheumatism. 58(11). 3632–3634. 37 indexed citations
7.
8.
Yue, Corinne Seng, et al.. (2008). Population Pharmacokinetic and Pharmacodynamic Analysis of Pegloticase in Subjects With Hyperuricemia and Treatment‐Failure Gout. The Journal of Clinical Pharmacology. 48(6). 708–718. 19 indexed citations
9.
Yamaguchi, Kazunari, Takashi Sawada, Seiichi Haga, et al.. (2001). Synthetic peptide-based electrochemiluminescence immunoassay for anti-Borna disease virus p40 and p24 antibodies in rat and horse serum. Annals of Clinical Biochemistry International Journal of Laboratory Medicine. 38(4). 348–355. 8 indexed citations
10.
Yamaguchi, Kazunari, Takashi Sawada, Ruriko Igata‐Yi, et al.. (1999). Detection of Borna Disease Virus-Reactive Antibodies from Patients with Psychiatric Disorders and from Horses by Electrochemiluminescence Immunoassay. Clinical and Diagnostic Laboratory Immunology. 6(5). 696–700. 43 indexed citations
11.
Waltrip, Royce W., Jeffrey Lieberman, Delbert G. Robinson, et al.. (1997). First episode schizophrenia and borna disease virus. Schizophrenia Research. 24(1-2). 261–261. 1 indexed citations
12.
Waltrip, Royce W., Robert W. Buchanan, William T. Carpenter, et al.. (1997). Borna disease virus antibodies and the deficit syndrome of schizophrenia. Schizophrenia Research. 23(3). 253–257. 57 indexed citations
13.
Waltrip, Royce W., Robert W. Buchanan, Ann Summerfelt, et al.. (1995). Borna disease virus and schizophrenia. Psychiatry Research. 56(1). 33–44. 94 indexed citations
14.
Breier, Alan, Robert W. Buchanan, Royce W. Waltrip, et al.. (1994). The Effect of Clozapine on Plasma Norepinephrine: Relationship to Clinical Efficacy. Neuropsychopharmacology. 10(1). 1–7. 95 indexed citations
15.
Aldrich, Carla J., Royce W. Waltrip, Evan Hermel, et al.. (1992). T cell recognition of QA-1b antigens on cells lacking a functional Tap-2 transporter. The Journal of Immunology. 149(12). 3773–3777. 52 indexed citations
16.
Carrigan, Donald R. & Royce W. Waltrip. (1990). Viral theories of schizophrenia. Current Opinion in Psychiatry. 3(1). 14–18. 3 indexed citations
17.
Waltrip, Royce W., Donald R. Carrigan, & William T. Carpenter. (1990). Immunopathology and Viral Reactivation. The Journal of Nervous and Mental Disease. 178(12). 729–738. 24 indexed citations
18.
Waltrip, Royce W., Milton E. Strauss, Ann Summerfelt, et al.. (1989). Rating affective flattening from videotaped interviews. Psychiatry Research. 27(2). 199–205.
19.
Kirkpatrick, Brian, et al.. (1989). Diazepam Treatment of Early Symptoms of Schizophrenic Relapse. The Journal of Nervous and Mental Disease. 177(1). 52–53. 14 indexed citations
20.
Waltrip, Royce W.. (1988). Insanity: The Idea and Its Consequences. American Journal of Psychiatry. 145(9). 1164–1165. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026